KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility
KindlyMD (NASDAQ: KDLY) announced a new partnership with Cigna Healthcare, expanding its insurance coverage to over 90% of Utah's population. The company has secured contracts with major providers including Select Health, Medicare, Medicaid, Blue Cross Blue Shield, and United Healthcare. As Utah's largest alternative pain treatment provider, KindlyMD has treated over 65,000 patient visits, focusing on integrating traditional primary care with behavioral and alternative therapies. The company aims to address the opioid crisis by providing alternative pain treatments, including medical cannabis evaluations, while ensuring safe opioid use when necessary through comprehensive care plans.
KindlyMD (NASDAQ: KDLY) ha annunciato una nuova partnership con Cigna Healthcare, ampliando la sua copertura assicurativa a oltre il 90% della popolazione nello Utah. L'azienda ha ottenuto contratti con principali fornitori, tra cui Select Health, Medicare, Medicaid, Blue Cross Blue Shield e United Healthcare. In quanto maggiore fornitore di trattamenti alternativi per il dolore nello Utah, KindlyMD ha gestito oltre 65.000 visite paziente, concentrandosi sull'integrazione delle cure primarie tradizionali con terapie comportamentali e alternative. L'azienda mira ad affrontare la crisi degli oppioidi offrendo trattamenti alternativi per il dolore, compresi i colloqui per la cannabis medicinale, garantendo al contempo un uso sicuro degli oppioidi quando necessario tramite piani di cura completi.
KindlyMD (NASDAQ: KDLY) anunció una nueva asociación con Cigna Healthcare, ampliando su cobertura de seguros a más del 90% de la población de Utah. La empresa ha asegurado contratos con proveedores principales, incluidos Select Health, Medicare, Medicaid, Blue Cross Blue Shield y United Healthcare. Como el mayor proveedor de tratamientos alternativos para el dolor en Utah, KindlyMD ha tratado más de 65,000 visitas de pacientes, centrándose en integrar la atención primaria tradicional con terapias conductuales y alternativas. La compañía busca abordar la crisis de los opioides proporcionando tratamientos alternativos para el dolor, incluidas las evaluaciones de cannabis medicinal, al mismo tiempo que garantiza un uso seguro de los opioides cuando sea necesario a través de planes de atención integrales.
KindlyMD (NASDAQ: KDLY)는 Cigna Healthcare와의 새로운 파트너십을 발표하여 유타주 인구의 90% 이상을 보험 범위에 포함시켰습니다. 이 회사는 Select Health, Medicare, Medicaid, Blue Cross Blue Shield 및 United Healthcare와 같은 주요 제공자와 계약을 체결했습니다. 유타주에서 가장 큰 대체 통증 치료 제공업체인 KindlyMD는 65,000건 이상의 환자 방문을 처리했으며, 전통적인 1차 치료와 행동 및 대체 요법을 통합하는 데 중점을 두고 있습니다. 이 회사는 의료용 대마초 평가를 포함한 대체 통증 치료를 제공함으로써 오피오이드 위기를 해결하는 것을 목표로 하며, 필요 시 포괄적인 치료 계획을 통해 안전한 오피오이드 사용을 보장합니다.
KindlyMD (NASDAQ: KDLY) a annoncé un nouveau partenariat avec Cigna Healthcare, étendant sa couverture d'assurance à plus de 90% de la population de l'Utah. L'entreprise a sécurisé des contrats avec des grands fournisseurs, y compris Select Health, Medicare, Medicaid, Blue Cross Blue Shield et United Healthcare. En tant que plus grand fournisseur de traitements alternatifs contre la douleur dans l'Utah, KindlyMD a traité plus de 65 000 consultations, en se concentrant sur l'intégration des soins primaires traditionnels avec des thérapies comportementales et alternatives. L'entreprise vise à lutter contre la crise des opioïdes en proposant des traitements alternatifs pour la douleur, y compris des évaluations de cannabis médical, tout en garantissant un usage sûr des opioïdes lorsque cela est nécessaire grâce à des plans de soins complets.
KindlyMD (NASDAQ: KDLY) hat eine neue Partnerschaft mit Cigna Healthcare angekündigt, die ihre Versicherungsdeckung auf über 90% der Bevölkerung von Utah ausweitet. Das Unternehmen hat Verträge mit großen Anbietern wie Select Health, Medicare, Medicaid, Blue Cross Blue Shield und United Healthcare gesichert. Als größter Anbieter von alternativen Schmerzbehandlungen in Utah hat KindlyMD über 65.000 Patientenbesuche behandelt und dabei den Fokus auf die Integration der traditionellen primären Versorgung mit Verhaltens- und Alternativtherapien gelegt. Das Unternehmen hat sich zum Ziel gesetzt, die Opioidkrise zu bekämpfen, indem es alternative Schmerzbehandlungen, einschließlich medizinischer Cannabisbewertungen, anbietet und gleichzeitig bei Bedarf durch umfassende Behandlungspläne einen sicheren Opioidgebrauch gewährleistet.
- Secured partnership with Cigna Healthcare, expanding insurance coverage to 90% of Utah's population
- Established contracts with major insurance providers (Select Health, Medicare, Medicaid, Blue Cross Blue Shield, United Healthcare)
- Achieved milestone of over 65,000 patient visits
- Positioned as Utah's largest alternative pain treatment provider
- None.
Insights
This partnership with Cigna Healthcare represents a significant expansion in KindlyMD's market reach, now covering
- Integration into major insurance networks (Cigna, Blue Cross Blue Shield, United Healthcare) validates their alternative pain management model
- Market positioning as Utah's largest alternative pain treatment provider with over 65,000 patient visits demonstrates strong market penetration
- Timing aligns with increasing demand for non-opioid pain management solutions amid the ongoing opioid crisis
The expanded insurance coverage should drive patient volume growth and revenue stability through broader accessibility. This development positions KindlyMD favorably in the evolving healthcare landscape, particularly as alternative pain management gains mainstream acceptance.
This insurance coverage expansion is strategically aligned with current healthcare policy trends and market demands. With CDC data showing 108,000 drug overdose deaths in 2021 and
KindlyMD now provides more than
SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it is now contracted with Cigna Healthcare, after receiving additional credentialing.
Cigna's innovative approach to behavioral health focuses on integrating mental health services with primary care and ensuring that individuals receive comprehensive support tailored to their unique needs. The inclusion of Cigna Healthcare marks another significant milestone for the Company, which has recently emerged as one of the first alternative medical treatment providers in the state to achieve this prestigious status, alongside contracts with Select Health, Medicare, and Medicaid. Following this achievement, KindlyMD also announced its contract with Blue Cross Blue Shield and United Healthcare, further solidifying its position in the healthcare landscape.
Tim Pickett, PA-C, KindlyMD founder and CEO, commented, "With the addition of Cigna Healthcare as the latest healthcare insurance provider, we continue to make a positive impact on healthcare accessibility as we have expanded our service reach and are now providing over
Provisional data released by the CDC's National Center for Health Statistics, reveals that nearly 108,000 people died of drug overdose in the U.S. in 2021, with over 80,000 of these deaths attributed to opioids. This prompted the government to initiate the largest opioid treatment grant funding ever. While recent CDC data shows that roughly
As Utah's largest alternative pain treatment facility, KindlyMD provides complete care plans in cases where opioids are needed to ensure safe use, appropriate dosing, weaning plans, and behavioral health support to curb risk. KindlyMD is also one of the largest providers of medical evaluation and management services related to treatment recommendations within the medical cannabis program in Utah. Notably, KindlyMD healthcare professionals provide patients with medical cannabis education and information to help patients decide whether medical cannabis may be a beneficial alternative treatment option for them, as part of its patient-first approach. Patients retain complete discretion to obtain their own medical cannabis, and KindlyMD does not sell or advertise cannabis products.
About KindlyMD
KindlyMD® is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.
For more information, please visit www.kindlymd.com.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including, but not limited to, the statements made under the heading "Risk Factors" in Kindly MD, Inc.'s Registration Statement on Form S-1 that was declared effective as of May 14, 2024. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com
SOURCE: KindlyMD
View the original press release on accesswire.com
FAQ
What insurance coverage does KindlyMD (KDLY) now provide in Utah as of October 2024?
How many patient visits has KindlyMD (KDLY) treated in their clinics?
What services does KindlyMD (KDLY) offer for pain management?
